Phaos Technology Holdings (Cayman) (POAS) Enterprise Value (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Enterprise Value came in at -$42673.9 in Q4 2025, up 55.97% on a QoQ basis from -$96918.3 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Enterprise Value (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Enterprise Value data on file, last reported at -$42673.9 in Q4 2025.
- Quarterly Enterprise Value changed N/A year-over-year to -$42673.9 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was -$42673.9 (changed N/A YoY) and the FY2025 annual result came in at -$97007.0, up 94.35% from the prior year.
- Enterprise Value advanced to -$42673.9 in Q4 2025, from -$96918.3 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$42673.9 in Q4 2025 to a low of -$1.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 4.24 Mn | 4.20 Mn | - | -42,673.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -42,673.91 |
| Apr 30, 2025 | -96,918.26 |
| Apr 30, 2024 | -1.72 Mn |